Icu Medical ICUI
NASDAQ ICUI
$152.65 -0.26 (-0.17%)
At close: Sep 18, 2026 · 4:00 PM EDT

Icu Medical (ICUI) Cash from Financing Activities (2009 - 2026)

Icu Medical's (ICUI) quarterly Cash from Financing Activities came in at -$50.2 million in Q2 2026, up 74.24% on a YoY basis from -$28.8 million in Q2 2025, and down 13.85% quarter-over-quarter from -$44.1 million in Q1 2026.

Analysis

Icu Medical (ICUI) Cash from Financing Activities (2009 - 2026) Analysis & Trends

Icu Medical (ICUI) has reported Cash from Financing Activities for 18 consecutive years, with -$50.2 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Cash from Financing Activities rose 74.24% year-over-year to -$50.2 million; the trailing twelve-month figure through Jun 2026 stood at -$154.5 million (up 42.75% YoY), and the FY2025 full-year result was -$311.5 million, down 458.29% from the prior year.
  • Cash from Financing Activities slipped to -$50.2 million in Q2 2026 per ICUI's latest filing, from -$44.1 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $1.6 billion in Q1 2022 and bottomed at -$195.0 million in Q2 2025.
  • Historically, Cash from Financing Activities has averaged $63.3 million across 5 years, with a median of -$10.4 million in 2022.
  • The sharpest annual moves came in 2022 and 2025: Cash from Financing Activities jumped 55063.9% in 2022, then slumped 1778.03% in 2025.
  • Over 5 years, Cash from Financing Activities stood at -$10.4 million in 2022, then gained by 24.42% to -$7.8 million in 2023, then decreased by 4.36% to -$8.2 million in 2024, then sank by 321.01% to -$34.5 million in 2025, then slumped by 45.67% to -$50.2 million in 2026.
  • According to Business Quant data, Cash from Financing Activities over the past three periods registered -$50.2 million, -$44.1 million, and -$34.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 177.43 Bn 172.48 Bn 7.27 Bn -3.52 Bn
2 Intuitive Surgical 139.20 Bn 134.11 Bn 1.96 Bn -287.90 Mn
3 Medtronic 118.01 Bn 109.81 Bn 6.34 Bn -343.00 Mn
4 Stryker 105.44 Bn 101.96 Bn 4.50 Bn -95.00 Mn
5 Boston Scientific 62.90 Bn 62.60 Bn 3.85 Bn -410.00 Mn
6 Edwards Lifesciences 50.87 Bn 46.72 Bn 1.35 Bn -300,000.00
7 Dexcom 33.72 Bn 31.77 Bn 830.00 Mn -607.30 Mn
8 Resmed 32.45 Bn 30.98 Bn 861.22 Mn -263.16 Mn
9 Alcon 31.70 Bn 30.25 Bn 1.68 Bn -510.00 Mn
10 Icu Medical 3.82 Bn 3.52 Bn 235.05 Mn -50.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -50.24 Mn
Mar 31, 2026 -44.12 Mn
Dec 31, 2025 -34.49 Mn
Sep 30, 2025 -25.69 Mn
Jun 30, 2025 -195.02 Mn
Mar 31, 2025 -56.34 Mn
Dec 31, 2024 -8.19 Mn
Sep 30, 2024 -10.38 Mn
Jun 30, 2024 -10.38 Mn
Mar 31, 2024 -26.85 Mn
Dec 31, 2023 -7.85 Mn
Sep 30, 2023 -6.40 Mn
Jun 30, 2023 -5.90 Mn
Mar 31, 2023 -15.84 Mn
Dec 31, 2022 -10.39 Mn
Sep 30, 2022 2.53 Mn
Jun 30, 2022 -4.03 Mn
Mar 31, 2022 1.65 Bn
Dec 31, 2021 -15.28 Mn
Sep 30, 2021 1.11 Mn